CBLL (CeriBell) Other Income (Expense): $5.8 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CBLL CeriBell Inc CBLL
12 GF Score
Price $24.25
! 5 Warning Signs
View Full Analysis

What is CeriBell Other Income (Expense)?

CeriBell CBLL -0.78% 12 Other Income (Expense) is $5.8 Mil as of Jun. 2026. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

CeriBell's other income expense for the CeriBell's pretax income for the three months ended in Jun. 2026 was $1.2 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2026 was $5.8 Mil.

CeriBell  (NAS:CBLL) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

CeriBell Other Income (Expense) Historical Data

* Premium members only.

The historical data trend for CeriBell's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Other Income (Expense) Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Income (Expense)
0.46 2.69 1.25 6.88

CeriBell Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Income (Expense) Get a 7-Day Free Trial 1.79 1.66 1.53 1.44 1.15
CBLL
12GF Score
CeriBell Inc CBLL
Other Income (Expense) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Income (Expense) →
What does a Other Income (Expense) of $5.8 Mil mean?
CeriBell (CBLL) has a Other Income (Expense) of $5.8 Mil as of Jun. 2026. Other income and expenses that a company records on the income statement. View historical data on CeriBell and its competitors.
Is CeriBell's Other Income (Expense) too high?
CeriBell's current Other Income (Expense) is $5.8 Mil. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's Other Income (Expense) compare to BBNX and SIBN?
CeriBell's Other Income (Expense) of $5.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Income (Expense) for a Medical Devices & Instruments company?
A good Other Income (Expense) depends on the Medical Devices & Instruments industry context. However, Other Income (Expense) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Income (Expense) mean?
A high Other Income (Expense) can signal that a stock is expensive relative to its fundamentals. Other income and expenses that a company records on the income statement. View historical data on CeriBell and its competitors. CeriBell's current Other Income (Expense) is $5.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current Other Income (Expense) of $5.8 Mil. The current Other Income (Expense) is $5.8 Mil. CeriBell's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Income (Expense) calculated?
Other Income (Expense) is calculated from a company's financial statements. For CeriBell (CBLL), the current Other Income (Expense) is $5.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CeriBell Business Description

Other Exchanges W3H:Germany
Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

Other Income (Expense) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.25
Price